Output

Endothelial Junctions

• Schossleitner K, Rauscher S, Gröger M, Friedl HP, Finsterwalder R, Habertheuer A, Sibilia M, Brostjan C, Födinger D, Citi S, Petzelbauer P. Evidence That Cingulin Regulates Endothelial Barrier Function In Vitro and In Vivo. Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):647-54. doi: 10.1161/ATVBAHA.115.307032. Epub 2016 Jan 28.
• Birner P, Heider S, Petzelbauer P, Wolf P, Kornauth C, Kuroll M, Merkel O, Steiner G, Kishimoto T, Rose-John S, Soleiman A, Moriggl R, Kenner L. Interleukin-6 Receptor Alpha Blockade Improves Skin Lesions in a Murine Model of Systemic Lupus Erythematosus. Exp Dermatol. 2016. Jan 6.
• Andreas M, Wiedemann D, Messner B, Hutschala D, Habertheuer A, Bernhard D, Petzelbauer P, Laufer G. Letter to the editor regarding "In vitro flow investigations in the aortic arch during cardiopulmonary bypass with stereo-PIV". J Biomech. 2015. Nov 19. pii: S0021-9290(15)00631-4. jbiomech.2015.09.051.
• Schossleitner K, Habertheuer A, Finsterwalder R, Friedl HP, Rauscher S, Gröger M, Kocher A, Wagner C, Wagner SN, Fischer G, Schultz MJ, Wiedemann D, Petzelbauer P. A Peptide to Reduce Pulmonary Edema in a Rat Model of Lung Transplantation. PLoS One.2015. Nov 4;10(11):e0142115.
• Holnthoner, W., Gröger, M., Pillinger, M., Wolff, K., Ashton A.W., Albanese, C., Neumeister, P., Pestell R.G., Petzelbauer, P.
  2002. Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J Biol Chem 277:45847-45853
• Halama, T., M. Gröger, M. Pillinger, G. Staffler, E. Prager, H. Stockinger, W. Holnthoner, S. Lechleitner, K. Wolff, P. Petzelbauer.
  2001. Platelet/endothelial cell adhesion molecule-1 and VE-cadherin / ß-catenin cooperatively regulate FGF-induced modulations of adherens junction functions. J Invest Dermatol 116:110-117
• Petzelbauer, P., Halama. T., Gröger, M.
  2000. Endothelial adherens junctions. J Invest Dermatol Symp Proc 5:10-13
• Matsumura, T., K. Wolff, P. Petzelbauer.
  1997. Endothelial cell tube formation depends on cadherin-5 and CD31 interactions with filamentous actin. J Immunol. 158:3408-3416.
• Halama, T., G. Staffler, S. Hoch, H. Stockinger, K. Wolff, P. Petzelbauer.
  1999. VE-cadherin but not PECAM-1-based cell to cell contacts convey the maintenance of a quiescent endothelial monolayer. Int Arch All Immunol 120:237-244

SCID-Mouse Model

• Puujalka E, Heinz M, Hoesel B, Friedl P, Schweighofer B, Wenzina J, Pirker C, Schmid JA, Loewe R, Wagner EF, Berger W, Petzelbauer P.Opposing roles of JNK and p38 in lymphangiogenesis in melanoma. J Invest Dermatol. 2016 Jan 29. pii: S0022-202X(16)00374-2. doi: 10.1016/j.jid.2016.01.020. [Epub ahead of print]
• Heinz M, Niederleithner HL, Puujalka E, Soler-Cardona A, Grusch M, Pehamberger H, Loewe R,Petzelbauer P. Activin A is anti-lymphangiogenic in a melanoma mouse model. J Invest Dermatol. 2015. Jan;135(1):212-21. Epub 2014 Aug 1.108(6):676-85
• Birner P, Berghoff AS, Dinhof C, Pirker C, Capper D, Schoppmann SF, Petzelbauer P, von Deimling A, Berger W, Preusser M. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.Arch Dermatol Res. 2014 Dec;306(10):873-84.  Epub 2014 Jul 30.
• Niederleithner H, Heinz M, Tauber S, Bilban M, Pehamberger H, Sonderegger S, Knöfler M, Bracher A, Berger W, Loewe R, Petzelbauer P.
  2012.Wnt1 Is Anti-Lymphangiogenic in a Melanoma Mouse Model.J Invest Dermatol.[Epub ahead of print]
• Leksa V, Loewe R, Binder B, Schiller HB, Eckerstorfer P, Forster F, Cardona AS, Ondrovicová G, Kutejová E, Steinhuber E, Breuss J, Drach J, Petzelbauer P, Binder BR, Stockinger H.
  2011.Soluble M6P/IGF2R Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation.Circ Res. 108(6):676-85
• Loewe R., Valero T., Kremling S., Pratscher B., Kunstfeld R., Pehamberger H., Petzelbauer P.
  2006. Dimethylfumarate impairs melanoma growth and metastasis, Cancer Res, Dec15;66(24).
• Kunstfeld R, Wickenhauser G, Umek W, Michaelis, U., Teifel, M., Naujoks, K., Wolff K., Petzelbauer, P.
  2003. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a ‘humanized’ SCID mouse model. J Invest Dermatol 120:476-482
• Kunstfeld, R., S. Lechleitner, K. Wolff, P. Petzelbauer.
  1998. MCP-1 and MIP-1a are most efficient in recruiting T cells into the skin in vivo. J Invest Dermatol. 111:1040-1044.
• Kunstfeld, R., S. Lechleitner, M. Gröger, K. Wolff and P. Petzelbauer.
  1997. HECA-452+ T Cells migrate through superficial vascular plexus but not through deep vascular plexus endothelium. J Invest Dermatol. 108:343-348
• Petzelbauer, P., M. Gröger, R. Kunstfeld, E. Petzelbauer, K. Wolff.
  1996. Human delayed type hypersensitivity reaction in a SCID mouse engrafted with human T cells and autologous skin. J Invest Dermatol. 107:576-581
• Murray, A. G., P. Petzelbauer, C. C. W. Hughes, J. Costa, P. Askenase, J. S. Pober.
  1994. Human T cell-mediated destruction of allogeneic dermal microvessels in a SCID mouse. Proc Natl Acad Sci USA. 91:9146-9150.

Melanoma

• Puujalka E, Heinz M, Hoesel B, Friedl P, Schweighofer B, Wenzina J, Pirker C, Schmid JA, Loewe R, Wagner EF, Berger W, Petzelbauer P. Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma. J Invest Dermatol. 2016 May;136(5):967-77. doi: 10.1016/j.jid.2016.01.020. Epub 2016 Jan 30.
• Bracher A, Cardona AS, Tauber S, Fink AM, Steiner A, Pehamberger H, Niederleithner H, Petzelbauer P, Gröger M, Loewe R.
  2013. Epidermal Growth Factor Facilitates Melanoma Lymph Node Metastasis by Influencing Tumor Lymphangiogenesis.J Invest Dermatol. 2013 Jan;133(1):230-8. Epub 2012 Sep 6.
• Swoboda A, Schanab O, Tauber S, Bilban M, Berger W, Petzelbauer P, Mikula M.
  2012.MET expression in melanoma correlates with a lymphangiogenic phenotype.Hum Mol Genet.[Epub ahead of print]
• Niederleithner H, Heinz M, Tauber S, Bilban M, Pehamberger H, Sonderegger S, Knöfler M, Bracher A, Berger W, Loewe R, Petzelbauer P.
  2012. Wnt1 is anti-lymphangiogenic in a melanoma mouse model. J Invest Dermatol
• Hoeth M, Niederleithner H, Bilban M, Mayer H, Hofer-Warbinek R, Wagner O, Petzelbauer P, de Martin R.
  2012. The transcription factor Sox18 controls a pattern of neuronal guidance molecules in endothelial cells. PLoS one 2012;7(1):e30982.
• Swoboda A, Rasin-Streden D, Schanab O, Okamoto I, Pehamberger H, Petzelbauer P, Mikula M.
  2011. Identification of genetic disparity between primary and metastatic melanoma in human patients. Genes, Chromosomes & Cancer. 50(9):680-8
• Valero T, Steele S, Neumüller K, Bracher A, Niederleithner H, Pehamberger H, Petzelbauer P, Loewe R.
  2010. Combination of Dacarbazine and Dimethylfumarate reduce melanoma lymph node metastasis. J Invest Dermatol. Apr;130(4):1087-94.
• Oble DA., Loewe R., Yu P., Mihm MC.Jr.
  2009. Focus on Melanoma TILs: Prognostic Significance and Immunobiology of Tumor Infiltrating Lymphocytes in the Age of Biological Therapy. Cancer Immunity. Apr 2;9:3.
• Loewe R., Valero T., Kremling S., Pratscher B., Kunstfeld R., Pehamberger H., Petzelbauer P.
  2006. Dimethylfumarate impairs melanoma growth and metastasis. Cancer Res. Dec15;66(24).
• Hoeller C., Thallinger C., Pratscher B., Bister MD., Schicher N., Loewe R., Heere-Ress E., Roka F., Sexl V., Pehamberger H.
  2005. The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells. J Invest Dermatol. Jun;124(6):1293-9.
• Loewe R, Kittler H, Fischer G, Faé I, Wolff K, Petzelbauer P.
  2004. Mutations in the BRAF kinase gene correlate with rapid melanocytic lesion growth. J Invest Dermatol 123:733-736
• Kunstfeld R, Wickenhauser G, Umek W, Michaelis, U., Teifel, M., Naujoks, K., Wolff K., Petzelbauer, P.
  2003. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a ‘humanized’ SCID mouse model. J Invest Dermatol 120:476-482

Cancer

• Capper D, Berghoff AS, Magerle M, Ilhan A, Wöhrer A, Hackl M, Pichler J, Pusch S, Meyer J, Habel A, Petzelbauer P, Birner , von Deimling A, Preusser M.
  2012.Immunohistochemical testing of BRAF V600E status in 1120 tumor tissue samples of patients with brain metastases. Acta Neuropathol ;123(2):223-33.
• Lill C, Schneider S, Item CB, Loewe R, Houben R, Halbauer D, Heiduschka G, Brunner M, Thurnher D.
  2011. P53 mutation is a rare event in Merkel cell carcinoma of the head and neck.Eur Arch Otorhinolaryngol. Nov;268(11):1639-46.
• Schneider S, Thurnher D, Kloimstein P, Leitner V, Petzelbauer P, Pammer J, Brunner M, Erovic BM.
  2010. Expression of the Sonic hedgehog pathway in squamous cell carcinoma of the skin and the mucosa of the head and neck. Head Neck. 33(2):244-50
• Brunner M, Thurnher D, Pammer J, Heiduschka G, Petzelbauer P, Schmid C, Schneider S, Erovic BM.
  2010. Expression of hedgehog signaling molecules in Merkel cell carcinoma. Head & Neck. Mar;32(3):333-40.
• Woegerbauer M, Thurnher D, Houben R, Pammer J, Kloimstein P, Heiduschka G, Petzelbauer P, Erovic BM.
  2010. Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a post-transcriptional fine-tuning of CD9 gene expression. Modern Pathology. May;23(5):751-62.
• Lichtenberger BM, Tan PK, Niederleithner H, Petzelbauer P, Sibilia M.
  2010. Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell. Jan 22;140(2):268-279.
• Pfistershammer K, Petzelbauer P, Stingl G, Mastan P, Chott A, Jäger U, Skrabs C, Geusau A.
  2010. Methotrexate-induced primary cutaneous diffuse large B-cell lymphoma with an 'angiocentric' histological morphology. Clin Exp Dermatol. Jan;35(1):59-62
• Brunner M, Thurnher D, Pammer J, Heiduschka G, Petzelbauer P, Schmid C, Schneider S, Erovic BM.
  2009. Expression of hedgehog signaling molecules in Merkel cell carcinoma.  Head & Neck.  Mar;32(3):333-40

Skin Inflammation

• Schuster C, Mildner M, Botta A, Nemec L, Rogojanu R, Beer L, Fiala C, Eppel W, Bauer W,Petzelbauer P, Elbe-Bürger A. Development of Blood and Lymphatic Endothelial Cells in Embryonic and Fetal Human Skin. Am J Pathol. 2015. Sep;185(9):2563-74. Epub 2015 Jul 16.
• Zeyda M, Gollinger K, Todoric J, Kiefer FW, Keck M, Aszmann O, Prager G, Zlabinger GJ, Petzelbauer P, Stulnig TM.
  2011. Osteopontin Is an Activator of Human Adipose Tissue Macrophages and Directly Affects Adipocyte Function. Endocrinology. 152(6):2219-27
• Reinisch CM, Mildner M, Petzelbauer P, Pammer J.
  2011. Embryonic stem cell factors undifferentiated transcription factor-1 (UFT-1) and reduced expression protein-1 (REX-1) are widely expressed in human skin and may be involved in cutaneous differentiation but not in stem cell fate determination. Int J Exp Pathol. 92(5):326-32
• Stary G, Klein I, Brüggen MC, Kohlhofer S, Brunner PM, Spazierer D, Müllauer L, Petzelbauer P, Stingl G.
  2010. Host Defense Mechanisms in Secondary Syphilitic Lesions. A Role for IFN-{gamma}-/IL-17-Producing CD8+ T Cells. Am J Pathol. 177(5):2421-32
• Siller-Matula JM, Bayer G, Bergmeister H, Quehenberger P, Petzelbauer P, Friedl P, Mesteri I, Jilma B.
  2010. An experimental model to study isolated effects of thrombin in vivo.Thromb Res.  Nov;126(5):454-61
• Pflegerl P, Janig E, Vesely P, Zenz R, Steiner G, Meixner A, Petzelbauer P, Wolf P, Soleiman A, Egger G, Moriggl R, Wagner EF and Kenner L.
  2009. Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signalling. PNAS 106(48) 20423-20428.
• Wick N, Haluza D, Gurnhofer E, Raab I, Kasimir MT, Prinz M, Steiner CW, Reinisch C, Howorka A, Giovanoli P, Buchsbaum S, Krieger S, Tschachler E, Petzelbauer P, Kerjaschki D.
  2008. Lymphatic precollectors contain a novel, specialized subpopulation of podoplaninlow, CCL27 secreting lymphatic endothelial cells Am J Pathol 173:1202-9
• Gröger M, Niederleithner H, Kerjaschki D and Petzelbauer P.
  2007. A previously unknown dermal blood vessel phenotype in skin inflammation. J Invest Dermatol 127:2893-2900
• Kohrgruber N, Gröger M, Meraner P, Kriehuber E, Petzelbauer P, Brandt S, Stingl G, Rot A, Maurer D.
  2004. Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J Immunol 173 6592-6602
• Holnthoner W, Kerenyi M, Gröger M, Kratochvill F, Petzelbauer P.
  2006. Regulation of Matrilysin Expression in Endothelium by Fibroblast Growth Factor-2. Biochem Biophys Res Commun 242: 725-733
• Gröger M, Loewe R, Holnthoner W, Embacher R, Pillinger M, Herron GS, Wolff K and Petzelbauer P.
  2004. IL-3 induces expression of lymphatic phenotypic markers Prox-1 and podoplanin in human endothelial cells. J Immunol 173:7161-9
• Loewe R, Holnthoner W, Gröger M, Pillinger M, Gruber F, Mechtcheriakova D, Hofer E, Wolff K, Petzelbauer P.
  2002. Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kB/p65 in human endothelial cells. J Immunol 168: 4781-7
• Gröger M., P. Petzelbauer.
  2001. Mikrovaskuläre Endothelzellen in der Haut exprimieren den Makrophagen Mannose Rezeptor (180kD) in situ und in vitro. Modern aspects of Immunobiology 2:28-29
• Loewe R, Pillinger M, Jirovsky D, Wiegrebe W, de Martin R, Mrowietz U, Gröger M, Holnthoner W, Wolff K, Petzelbauer P.
  2001. Dimethylfumarate inhibits TNF-induced CD62E expression in a NFκB-dependent manner. J Invest Dermatol 117:1363-1368
• Kriehuber E, Breiteneder-Geleff S, Groeger M, Soleiman A, Schoppmann SF,Stingl G, Kerjaschki D, Maurer D.
  2001. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med.Sep 17; 194(6):797-808.
• Gröger, M., W. Holnthoner, D. Maurer, S. Lechleitner, K. Wolff, B. Mayr, W. Lubitz, and P. Petzelbauer.
  2000. Dermal microvascular endothelial cells express the 180 kD macrophage mannose receptor in situ and in vitro. J Immunol 165:5428-5434
• Gröger, M., G. F. Fischer, K. Wolff, P. Petzelbauer.
  1999. Immune complexes from vasculitis patients bind to endothelial Fc receptors independent of the allelic polymorphism of FcgRIIa. J Invest Dermatol. 113:56-60
• Lechleitner, S., R. Kunstfeld, C. Messeritsch-Fanta, K. Wolff, P. Petzelbauer.
  1999. Peripheral node addressins are expressed on skin endothelial cells. J Invest Dermatol 113:410-414
• Gröger, M., T. Matsumura, N. Kohrgruber, D. Maurer, K. Wolff, P. Petzelbauer.
  1999. A standardized, computer-assisted in vitro assay for the assessment of neutrophil transmigration across endothelial monolayers. J Immunol Meth 222:101-109
• Kohrgruber N, Halanek N, Gröger M, Winter D, Rappersberger K, Schmitt-Egenolf M, Stingl G, Maurer D.
  1999. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol. Sep 15;163(6):3250-9.
• Lechleitner, S., J. Gille, D. R. Johnson, P. Petzelbauer.
  1998. Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway. J Exp Med. 187:2023-2030.
• Ure, I., B. Partsch, K. Wolff, P. Petzelbauer.
  1998. GM-CSF increases wound fluid IL-8, but does not accelerate wound healing in healthy subjects. Brit J Dermatol. 138:277-282.
• Maurer, D., E. Fiebiger, B. Reininger, C. Ebner, P. Petzelbauer, Guo-Ping Shi, H. A. Chapmann, G. Stingl.
  1998. FceRI on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC Class II presentation. J Immunol. 161:2731-2739.
• Pickl, W., O. Majdic, G. Fischer, P. Petzelbauer, I. Faé, M. Waclavicek, J. Stöckl, C. Scheinecker, T. Vidicki, H. Aschauer, J. P. Johnson, W. Knapp.
  1997. MUC18/MCAM (CD146): An activation antigen of human T lymphocytes. J Immunol. 158:2107-2115.
• Petzelbauer, P., M. Gröger.
  1997. Cutaneous immune complex vasculitis: the role of Fc gamma receptors in precipitating the disease. J Dermatol. 24:730-731.
• Maurer, D., C. Ebner, B. Reininger, P. Petzelbauer, E. Fiebiger, G. Stingl.
  1997. Mechanisms of Fc epsilon RI-IgE-facilitated allergen presentation by dendritic cells. Adv Exp Med Biol. 417:175-178.
• Gröger, M., G. Sarmay, E. Fiebiger, K. Wolff, P. Petzelbauer.
  1996. Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro. J Immunol. 156:1549-1556.
• Petzelbauer, P., C. A. Watson, S. E. Pfau, J. S. Pober.
  1995. IL-8 and angiogenesis: evidence that human endothelial cells lack IL-8 receptors and do not respond in vitro. Cytokine. 7:267-272.
• Watson, C. A., P. Petzelbauer, J. Zhou, R. Pardi, J. R. Bender.
  1995. Contact-dependent endothelial cell class II HLA gene activation induced by natural killer cells is mediated by IFN-g -dependent and independent mechanisms. J Immunol. 154:3222-3232
• Petzelbauer, P., J. S. Pober, A. Key, I. M. Braverman.
  1994. Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional and uninvolved skin of psoriatic patients. J Invest Dermatol. 103:300-305.
• Petzelbauer, P., J. R. Bender, J. Wilson, J. S. Pober.
  1993. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol. 151:5062-5072
• Petzelbauer, P., H. Hönigsmann, K. Langer, B. Anegg, R. Strohal, A. Tanew, K. Wolff.
  1990. Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis. Brit J Dermatol. 123:641-647.

Fibrinopeptide Bβ15-42

• Sörensen I, Rong S, Susnik N, Gueler F, Shushakova N, Albrecht M, Dittrich AM, von Vietinghoff S, Becker JU, Melk A, Bohlmann A, Reingruber S, Petzelbauer P, Haller H, Schmitt R. 2011. Fibrinogen derived Bß15–42 improves renal allograft survival by attenuating reperfusion injury and inflammation .J Am Soc Nephrol. 22(10):1887-96
• Kretschy D, Gröger M, Zinkl D, Petzelbauer P, Koellensperger G, Hann S.
  2011. High-throughput flow injection analysis of labeled peptides in cellular samples—ICP-MS analysis versus fluorescence based detection. Int J Mass Spectrom. 307:105-111
• Wiedemann D, Schneeberger S, Friedl P, Zacharowski K, Zacharowski K, Wick N, Boesch F, Margreiter R, Laufer G, Petzelbauer P, Semsroth S.
  2010. The fibrin-derived peptide Bβ15-42 significantly attenuates ischemia/reperfusion injury in a cardiac transplant model. Transplantation Apr 15;89(7):824-9.
• Hallén J, Petzelbauer P, Schwitter J, Henning R, Buser P, Atar D.
  2010. Impact of time to therapy on the efficacy of FX06 in acute ST elevation myocardial infarction: a F.I.R.E. substudy. EuroIntervention. Apr;5(8):946-52.
• Hallen J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D.
  2009. Cardiac Troponin I Measurements at 24 and 48 Hours Predict Infarct Size in Patients with ST elevation Myocardial Infarction - A cardiac magnetic resonance study. Am J Cardiol Dec 1; 104(11) 1472-1477.
• Matt U, Warszawska JM, Bauer M,Dietl W, Mesteri I, Doninger B, Haslinger I, Schabbauer G,Perkmann T, Binder CJ, Reingruber S, Petzelbauer P and Knapp S.
  2009. Bβ15-42 protects against acid-induced acute lung injury and secondary Pseudomonas pneumonia in vivo. Am. J. Respir. Crit. Care Med., Published ahead of print on September 17, 2009
• Gröger M, Pasteiner W, Ignatyev G, Matt U, Knapp S, Atrasheuskaya A, Bukin E, Friedl P, Zinkl D, Hofer-Warbinek R, Zacharowski K, Petzelbauer P and Reingruber S.
  2009. Peptide Bβ15-42 preserves endothelial barrier function in shock. plos ONE 4(4): e5391
• Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Süselbeck T, Clemmensen PM, Marin-Galiano M, Geudelin B, Buser PT; F.I.R.E. Investigator
  2009. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol. Feb 24;53(8):720-9.
• Roesner JP, Petzelbauer P, Koch A, Tran N, Iber T, Vagts DA, Scheeren TW, Vollmar B, Nöldge-Schomburg GE, Zacharowski K.
  2009. Bbeta15-42 (FX06) reduces pulmonary, myocardial, liver, and small intestine damage in a pig model of hemorrhagic shock and reperfusion. Crit Care Med. Feb;37(2):598-605.
• Roesner JP, Petzelbauer P, Koch A, Tran N, Iber T, Mutz C, Vollmar B, Nöldge-Schomburg GE, Zacharowski K.
  2009. A double blind, single centre, sub-chronic reperfusion trial evaluating FX06 following haemorrhagic shock in pigs. Resuscitation. Feb;80(2):264-71.
• Koellensperger G, Gröger M, Zinkl D, Petzelbauer P, Hann S.
  2009. Quantification of elemental labeled peptides in cellular uptake studies. J Anal Atom Spectrom, 24, 97 - 102, DOI: 10.1039/b807397j
• Zacharowski K, Petzelbauer P. 2007. The peptide Bbeta15-42: A new treatment option for the heart in shock? Inflammation Res 56: S194-S195
• Roesner J, Petzelbauer P, Koch A, Mersmann J, Zacharowski PA, Boehm O, Reingruber S, Pasteiner W, Henning R, Mascher H, Mascher D, Barthuber C, Nöldge-Schomburg G, Scheeren TW, Zacharowski K.
  2007. The fibrin-derived peptide Bβ15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury. Crit Care Med 35:1730-1735.
• Zacharowski K, Zacharowski PA, Friedl P, Mastan P, Koch A, Boehm O, Rother RP, Reingruber S, Henning R, Emeis JJ, Petzelbauer P.
  2007. A preclinical study in three different centers on the effects of the fibrin-derived peptide Bβ15-42 in rodent models of myocardial ischemia-reperfusion. Shock 27, 631-7
• Henning R, Zacharowski K, Petzelbauer P.
  2006. FX06 (fibrin-derived peptide Bbeta15-42) – A Potential Candidate for Myocardial Reperfusion Therapy. Drugs of the future 31, 811-19
• Zacharowski K, Zacharowski P, Reingruber S, Petzelbauer P.
  2006. Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction. J Mol Med 84:469-77
• Petzelbauer P, Zacharowski P, Miyazaki Y, Friedl P, Wickenhauser G, Castellino F, Gröger M, Wolff K, Zacharowski K.
  2005. The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia/reperfusion injury. Nat Med 11 298-304
• Atrasheuskaya, A., Petzelbauer, P., Fredeking, T.M., Ignatyev, G.
  2003. Anti-TNF antibody treatment reduces mortality in experimental Dengue virus infection. FEMS Immunol Med Mic 35:33-42

Clinical papers

• Birner P, Heider S, Petzelbauer P, Wolf P, Kornauth C, Kuroll M, Merkel O, Steiner G, Kishimoto T, Rose-John S, Soleiman A, Moriggl R, Kenner L. Interleukin-6 Receptor Alpha Blockade Improves Skin Lesions in a Murine Model of Systemic Lupus Erythematosus.Exp Dermatol. 2016. Jan 6. [Epub ahead of print]
• Brüggen MC, Petzelbauer P, Greinix H, Contassot E, Jankovic D, French L, Socié G, Rabitsch W, Kuzmina Z, Kalhs P, Knobler R, Stingl G, Stary G. Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease. J Invest Dermatol. 2015. Apr;135(4):999-1006. Epub 2014 Nov 18.
• Habertheuer A, Kocher A, Laufer G, Andreas M, Szeto WY, Petzelbauer P, Ehrlich M, Wiedemann D. Cardioprotection: a review of current practice in global ischemia and future translational perspective. Biomed Res Int. 2014;2014:325725. Epub 2014 Sep 8. Review.
• Leitner V, Weingast J, Harmankaya K, Walochnik J, Pehamberger H, Petzelbauer P, Auer H, Binder M.
  2010. Leishmaniasis in the tongue of an immunocompetent man. Am J Trop Med Hyg. Apr;82(4):597-9
• Loewe R, Gattringer KB, Petzelbauer P.
  2009. Janeway Lesions may present with inconspicuous histological features. 2009. J Cutan Pathol. Jan 27. [Epub ahead of print]
• Pfistershammer K, Petzelbauer P, Mastan P, Chott A, Jäger U, Skrabs C, Geusau A. 2008. MTX-induced primary cutaneous diffuse large B-cell lymphoma with an angiocentric histological morphology. Clin Exp Dermatol 2009 May 21. [Epub ahead of print]
• Brunner M, Thurnher D, Pammer J, Geleff S, Heiduschka G, Reinisch CM, Petzelbauer P, Erovic BM.
  2008. Expression of VEGF-A/C, VEGF-R2, PDGF-B1 and B2, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma. Mod Pathol 21:876-84.
• Winter D, Moser J, Kriehuber E, Wiesner C, Knobler R, Trautinger F, Bombosi P, Stingl G, Petzelbauer P, Rot, A, Maurer D.
  2007. Down-Modulation of CXCR3 Surface Expression and Function in CD8+ T Cells from Cutaneous T Cell Lymphoma Patients. J Immunol 179:4272-82
• Dzirlo L, Hubner M, Müller C, Blaha B, Formann E, Dellinger C, Petzelbauer P, Müllauer L, Huber K, Kneussl M, Gschwantler M.
  2007. A mimic of sarcoidosis. Lancet 369:1832
• Streubel B, Scheucher B, Valencak J, Huber D, Petzelbauer P, Trautinger F, Weihsengruber F, Mannhalter C, Cerroni L, Chott A.
  2006. Molecular Cytogenetic Evidence of t(14;18)(IGH;BCL2) in a Substantial Proportion of Primary Cutaneous Follicle Center Lymphomas. Am J Surg Pathol 30:529-536.
• Loewe R, Palatin M, Petzelbauer P.
  2005. Degos´ disease with inconspicuous clinical course. J Europ Acad Derm Ven 19: 477-480
• Loewe R, Püspök-Schwarz M und Petzelbauer P.
  2003. Apomorphin-Pigmentierung. Hautarzt 54:58-63
• Wolff, K., Komar, M., Petzelbauer, P.
  2001. Clinical and histopathological aspects of cutaneous mastocytosis. Leukemia Res 25:519-528
• Wolf, H.M., V. Thon, H. Gulle, S. Lechleitner, M.M. Eibl, and P. Petzelbauer.
  2001. Cell-specific residual expression of MHC class II molecules in twin brothers with a new form of MHC class II deficiency. Br J Hematology 115:460-471
• Kunstfeld, R., P. Petzelbauer, G., Wickenhauser, I. Schlenz, K. Korak, K. Vinzenz, J. Holle.
  2001. The prefabricated scapula flap consists of syngeneic bone, connective tissue and a self-assembled epithelial coating. Plast Reconstruct Surg 108:1908-1914
• Haller, A., E. Elzubi, P. Petzelbauer.
  2001. A female patient with localized syringolymphoid hyperplasia with alopecia and anhidrosis. J Am Acad Dermatol 45:127-130
• Kunstfeld, R., P. Petzelbauer.
  2001. A unique case of a benign disseminated angioproliferation combining features of Kaposi’s sarcoma and diffuse dermal angioproliferation. J Am Acad Dermatol 45:601-605
• Weninger, W., M. Rendl, J. Pammer, W. Grin, P. Petzelbauer, E. Tschachler.
  1997. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behavior. J Cut Pathol. 24:364-369
• Petzelbauer, P., D. Födinger, C. Rappersberger, B. Volc Platzer, K. Wolff.
  1993. CD68 positive epidermal cells. J Invest Dermatol. 101:256-261
• Petzelbauer, P., K. Wolff, G. Tappeiner.
  1992. Necrobiosis lipoidica: treatment with systemic corticosteroids. Brit J Dermatol. 126:542-545.
• Petzelbauer, P., K. Wolff.
  1992. Effects of cyclosporin A on resident and passenger immune cells of normal human skin and UV-induced erythema reactions. Brit J Dermatol. 127:560-565.
• Petzelbauer, P., M. Binder, P. Nikolakis, B. Ortel, H. Hönigsmann.
  1992. Severe sun sensitivity and the presence of antinuclear antibodies in patients with polymorphous light eruption-like lesions. A form fruste of photosensitive lupus erythematosus? J Am Acad Dermatol. 26:68-74.
• Aberer, W., A. Steiner, P. Petzelbauer. 1991. Klinik, Diagnostik, Therapie and Prophylaxe der Penicillinallergie. Therapiewoche. 6:165-172.
• Petzelbauer, P., G. Stingl, K. Wolff, B. Volc Platzer.
  1991. Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol. 96:362-369.
• Petzelbauer, P., K. Konrad.
  1990. Polypous clear cell acanthoma. Am J Dermatopathology. 12:393-395
• Petzelbauer P, K. Konrad, K Wolff.
  1989. Staphylococcal scalded skin syndrome in 2 adults with acute kidney failure. Hautarzt. 40:90-93.
• Petzelbauer, P., I. Hammer, K. Konrad.
  1989. Cornu cutaneum. Hautarzt. 40:556-558.